Europe Animal Healthcare Market 2024–2033

Reports Description

As per the current market research conducted by Custom Market Insight Market Research Team, the global Europe Animal Healthcare market is expected to record a CAGR of 4.5% from 2023 to 2030. In 2023, the market size is projected to reach a valuation of USD 41.65 billion. By 2030, the valuation is anticipated to reach US$ 56.68 billion.

The Europe Animal Healthcare market refers to the industry that provides a range of products and services related to the health and well-being of animals in Europe. This market includes pharmaceuticals, vaccines, diagnostics, feed additives, and other products that are used for the prevention and treatment of diseases in both pets and livestock.

The animal healthcare market in Europe is driven by various factors, such as the increasing pet adoption rate, the growing demand for animal-based products, and the rising prevalence of zoonotic diseases. It is a significant market that plays a vital role in ensuring the health and welfare of animals in Europe.

Europe Animal Healthcare Market – Significant Growth Factors

There are several significant growth drivers for the Europe Animal Healthcare Market, including:

• Increase in pet adoption rate: The high per-capita income in Europe has led to an increase in pet ownership, resulting in a rise in demand for animal healthcare products and services.
• Growing demand for animal-based products: The demand for animal-based products, such as meat, milk, and eggs, has been steadily increasing in Europe, leading to a rise in demand for animal healthcare products that can ensure the health and well-being of livestock.
• Rise in prevalence of zoonotic diseases: The occurrence of zoonotic diseases, which can spread from animals to humans, has been increasing in Europe. This has resulted in a higher demand for animal healthcare products and services to prevent and treat these diseases.
• Technological advancements in animal healthcare: The development of new technologies and treatments for animal diseases has led to an increase in demand for animal healthcare products and services.
• Government initiatives to promote animal health: Governments in Europe are taking steps to improve animal health and welfare, leading to an increase in demand for animal healthcare products and services.

Overall, these growth drivers are expected to contribute significantly to the growth of the Europe Animal Healthcare market in the coming years.

Europe Animal Healthcare Market – Mergers and Acquisitions

The Europe Animal Healthcare market has seen a significant number of mergers and acquisitions in recent years. Some notable ones include:

1. Zoetis Inc. acquired PHARMAQ, a leading global aquaculture health company, in 2015. This acquisition helped Zoetis expand its presence in the fast-growing aquaculture market.
2. Elanco Animal Health acquired the animal health business of Bayer AG in 2020 for $7.6 billion. This acquisition helped Elanco become the second-largest animal health company in the world.
3. Boehringer Ingelheim acquired Merial, the animal health business of Sanofi, in 2017. This acquisition helped Boehringer Ingelheim become the second-largest animal health company in the world.
4. Ceva Santé Animale acquired Polchem, a Polish animal health company, in 2019. This acquisition helped Ceva expand its presence in the Central and Eastern Europe market.
5. Virbac acquired SentrX Animal Care, a US-based animal health company, in 2020. This acquisition helped Virbac expand its product portfolio in the US market.

Overall, these mergers and acquisitions have helped companies in the Europe Animal Healthcare market expand their presence in new markets, diversify their product portfolios, and improve their competitiveness.

COMPARATIVE ANALYSIS OF THE RELATED MARKET

Europe Animal Healthcare Market – Significant Threats

The Europe Animal Healthcare Market faces several significant threats, including:

1. Stringent regulations: The animal healthcare market is subject to strict regulations governing the safety and efficacy of animal healthcare products. Non-compliance with these regulations can lead to heavy fines, product recalls, and damage to the reputation of the company.
2. The outbreak of animal diseases: The outbreak of animal diseases can have a severe impact on the animal healthcare market, leading to a decline in demand for animal healthcare products and services.
3. Competition from generics: The availability of low-cost generic versions of animal healthcare products can pose a significant threat to companies in the animal healthcare market.
4. Price sensitivity: The animal healthcare market is highly price-sensitive, and companies must price their products competitively to remain profitable.
5. Economic downturns: Economic downturns can lead to a decline in demand for animal healthcare products and services as pet owners and farmers may cut back on non-essential expenses.

Overall, these threats highlight the challenges faced by companies operating in the Europe Animal Healthcare market, and they must develop effective strategies to mitigate these risks and remain competitive in the market.

Report Scope

Category-Wise Insights

By Product:

In 2022, the veterinary services segment in Europe was valued at USD 19.5 billion, which can be attributed to the increasing demand for services such as animal training, day care, and grooming. These services play a crucial role in safeguarding animal health and welfare. Additionally, the rise in zoonotic diseases has resulted in a significant surge in demand for veterinary services. The UK alone has reported significant economic losses due to such diseases. Moreover, the increasing demand for animal-based products has also contributed to the demand for these services to ensure the welfare of animals.

By Animal Type:

The companion animals segment dominated the Europe Animal Healthcare market in 2022, accounting for over 58% of the market share. This significant share can be attributed to favorable government initiatives for animal health, advancements in companion animal healthcare facilities, and the increasing trend of pet adoption. The market growth is further propelled by the rise in pet adoption and increased spending on pet healthcare due to higher disposable income. According to the European Pet Food Industry data, approximately 85 million households across the European Union own at least one pet. Additionally, the usage of pets in films and ad campaigns has increased the overall attraction towards pet adoption among the European population.

By Distribution Channel:

The pharmacies segment of the Europe Animal Healthcare market is expected to generate revenue of USD 16.5 billion by 2030. The growing consumption of animal healthcare medications is a crucial factor driving the growth of this segment.

The increasing number of livestock and companion animals, rising instances of animal surgeries, and a surge in zoonotic diseases are some of the factors contributing to the growth of the pharmacies segment. Additionally, a large number of consumers prefer the convenience of having veterinary pharmacies located in their vicinity to fulfill their animal healthcare needs.

Europe Animal Healthcare Market – Regional Analysis

Europe is a significant region for the animal healthcare market. The region is divided into several key countries, including the UK, Germany, France, Italy, Spain, and the Rest of Europe.

• The UK accounted for a significant share of the Europe Animal Healthcare market in 2020, owing to the high number of pet owners and favorable government initiatives for animal health. Additionally, the presence of major players in the region is expected to drive the market growth.
• Germany is also a prominent player in the Europe Animal Healthcare market, owing to the increasing trend of pet ownership and the growing awareness of animal health. The country has a high number of livestock and companion animals, which creates significant demand for animal healthcare products and services.
• France is another important market in the region, driven by the high consumption of animal-based products, favorable government initiatives for animal health, and increasing pet adoption. Additionally, the presence of major players in the country is expected to further propel the market growth.
• Italy and Spain also contribute significantly to the European Animal Health Market, owing to the high number of livestock and companion animals in the region. The demand for animal healthcare products and services is expected to rise due to the increasing awareness of animal health and the growing trend of pet ownership in these countries.

Competitive Landscape – Europe Animal Healthcare Market

The Europe Animal Healthcare market is highly competitive and fragmented, with several major players competing for market share. Some of the key players operating in the market include

• Zoetis Inc.
• Elanco,
• Merck & Co. Inc.
• Boehringer Ingelheim International GmbH
• Bayer AG
• Virbac
• Ceva Santé Animale
• Vetoquinol
• Dechra Pharmaceuticals PLC
• IDEXX Laboratories Inc.
• Others

These companies are focusing on various growth strategies, such as partnerships, collaborations, mergers and acquisitions, and new product launches, to strengthen their position in the market. For instance, in 2020, Zoetis Inc. completed the acquisition of Performance Livestock Analytics, a livestock analytics software company. This acquisition is expected to enhance the company’s digital and data analytics capabilities in the livestock sector. Similarly, in 2021, Elanco completed the acquisition of Kindred Biosciences, a biopharmaceutical company. This acquisition is expected to strengthen Elanco’s position in the companion animal market by expanding its pipeline of innovative products.

Other key players in the market are also investing in research and development activities to introduce new and innovative products in the market. These companies are also expanding their geographic presence through strategic partnerships and collaborations with local players.

The Europe Animal Healthcare Market is segmented as follows: